The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Dowden Nathan J since 2022.
This trader's CIK number is 1873392.
At the time of last reporting, Dowden Nathan J was the President & COO of Entrada Therapeutics, Inc.. (stock ticker symbol TRDA).
Also see all insider trading activities at Entrada Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2024 | TRDA | 0 | $0 | 32,073 | $517,332 | 20,000 | $34,800 |
| 2023 | TRDA | 0 | $0 | 24,051 | $387,680 | 0 | $0 |
| 2022 | TRDA | 0 | $0 | 29,479 | $506,465 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2024-09-26 | TRDA | Sale | 847 | 16.00 | 13,552 |
| 2024-09-06 | TRDA | Sale | 399 | 15.20 | 6,062 |
| 2024-09-09 | TRDA | Sale | 1,904 | 15.07 | 28,689 |
| 2024-08-16 | TRDA | Sale | 27,097 | 16.48 | 446,531 |
| 2024-08-16 | TRDA | Option Ex | 20,000 | 1.74 | 34,800 |
| 2024-03-06 | TRDA | Sale | 1,826 | 12.32 | 22,498 |
| 2023-09-06 | TRDA | Sale | 972 | 13.72 | 13,334 |
| 2023-07-10 | TRDA | Sale | 3,200 | 18.00 | 57,606 |
| 2023-07-11 | TRDA | Sale | 3,897 | 18.05 | 70,333 |
| 2023-06-20 | TRDA | Sale | 8,885 | 14.94 | 132,706 |
| 2023-06-22 | TRDA | Sale | 7,097 | 16.02 | 113,701 |
| 2022-10-25 | TRDA | Sale | 9,348 | 20.98 | 196,083 |
| 2022-10-20 | TRDA | Sale | 905 | 18.07 | 16,356 |
| 2022-10-21 | TRDA | Sale | 2,771 | 18.29 | 50,667 |
| 2022-10-24 | TRDA | Sale | 2,404 | 19.27 | 46,325 |
| 2022-09-26 | TRDA | Sale | 1,544 | 15.78 | 24,370 |
| 2022-09-21 | TRDA | Sale | 3,275 | 15.13 | 49,537 |
| 2022-09-23 | TRDA | Sale | 1,018 | 15.07 | 15,340 |
| 2022-09-15 | TRDA | Sale | 100 | 15.01 | 1,501 |
| 2022-09-15 | TRDA | Sale | 100 | 15.01 | 1,501 |
| 2022-09-15 | TRDA | Sale | 100 | 15.01 | 1,501 |
| 2022-09-15 | TRDA | Sale | 100 | 15.01 | 1,501 |
| 2022-09-15 | TRDA | Sale | 100 | 15.01 | 1,501 |
| 2022-06-27 | TRDA | Sale | 7,714 | 13.00 | 100,282 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Dowden Nathan J (President & COO of Entrada Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.